Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.58 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.58 |
| ▸ | FAAH | O00519 | 4/20 | 0.50 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | TERT | O14746 | 2/20 | 0.47 |
| ▸ | GMNN | O75496 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | APEX1 | P27695 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL856860 | 1.00 | FFAR1 (0.58) | FFAR1FFAR4FAAHTRPV1GPR84 | |
| SCHEMBL1408742 | 1.00 | FFAR1 (0.58) | FFAR1FFAR4FAAHTRPV1GPR84 | |
| SCHEMBL2701175 | 1.00 | FFAR1 (0.58) | FFAR1FFAR4FAAHTRPV1GPR84 | |
| SCHEMBL1408280 | 1.00 | FFAR1 (0.58) | FFAR1FFAR4FAAHTRPV1GPR84 | |
| SCHEMBL1408278 | 1.00 | FFAR1 (0.58) | FFAR1FFAR4FAAHTRPV1GPR84 | |
| SCHEMBL17744144 | 0.96 | FFAR1 (0.62) | FFAR1FFAR4FAAHTRPV1GPR84 | |
| SCHEMBL6008572 | 0.96 | FFAR1 (0.62) | FFAR1FFAR4FAAHTRPV1GPR84 | |
| SCHEMBL2933857 | 0.96 | FFAR1 (0.62) | FFAR1FFAR4FAAHTRPV1GPR84 | |
| SCHEMBL1070641 | 0.96 | FFAR1 (0.62) | FFAR1FFAR4FAAHTRPV1GPR84 | |
| SCHEMBL3185051 | 0.96 | FFAR1 (0.62) | FFAR1FFAR4FAAHTRPV1GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240156704-A1 | FORMULATION COMPRISING ESTER QUATS BASED ON TRIALKANOLAMINES | EVONIK OPERATIONS GMBH (DE) | 2024-05-16 | — | — | US | disclosed |
| EP-4360617-A1 | FORMULATION COMPRISING ESTER QUATS BASED ON TRIALKANOLAMINES | Evonik Operations GmbH (DE) | 2024-05-01 | — | — | EP | disclosed |
| US-11692153-B2 | Long-chain alkyl esterquats for highly viscous laundry and cleaning formulations | EVONIK OPERATIONS GMBH (DE) | 2023-07-04 | — | — | US | disclosed |
| CN-112566613-B | Mixed quaternary ammonium salts, particularly in hair treatment compositions | 赢创运营有限公司 | 2023-05-26 | — | — | CN | disclosed |
| EP-2475432-B2 | Cosmetic spray formulation with antimicrobial effect | DALLI WERKE GMBH & CO KG (DE) | 2023-05-10 | — | — | EP | disclosed |
| US-11517515-B2 | Hybrid quats in, in particular, hair treatment agents | EVONIK OPERATIONS GMBH (DE) | 2022-12-06 | — | — | US | disclosed |
| CN-112368362-B | Active composition for high viscosity laundry cleaning formulations | 赢创运营有限公司 | 2022-05-24 | — | — | CN | disclosed |
| EP-2783677-B1 | Formulation comprising ester quats based on isopropanolamine | EVONIK OPERATIONS GMBH (DE) | 2022-05-04 | — | — | EP | disclosed |
| US-20210277329-A1 | ACTIVE COMPOSITIONS FOR HIGHLY VISCOUS LAUNDRY AND CLEANING FORMULATIONS | EVONIK OPERATIONS GMBH (DE) | 2021-09-09 | — | — | US | disclosed |
| US-20210251865-A1 | HYBRID QUATS IN, IN PARTICULAR, HAIR TREATMENT AGENTS | EVONIK OPERATIONS GMBH (DE) | 2021-08-19 | — | — | US | disclosed |
| US-20140286889-A1 | FORMULATION COMPRISING ESTER QUATS BASED ON ISOPROPANOLAMINE | EVONIK INDUSTRIES AG (DE) | 2014-09-25 | — | — | US | disclosed |
| EP-2475432-A2 | COSMETIC COMPOSITION WITH AN ANTIMICROBIAL EFFECT | Dalli-Werke GmbH & Co. KG (DE) | 2012-07-18 | — | — | EP | disclosed |
| WO-2011029516-A2 | COSMETIC COMPOSITION WITH AN ANTIMICROBIAL EFFECT | DALLI-WERKE GMBH & CO. KG (DE) | 2011-03-17 | — | — | WO | disclosed |
| EP-2295114-A1 | Cosmetic compound with antimicrobial effect | Dalli-Werke GmbH & Co. KG (DE) | 2011-03-16 | — | — | EP | disclosed |
| US-20100179346-A1 | METHOD FOR HYDROGENATING GLYCEROL | EMERY OLEOCHEMICALS GMBH (DE) | 2010-07-15 | — | — | US | disclosed |
| US-20100168255-A1 | METHOD FOR PRODUCING A COMPOUND WHICH HAS AT LEAST ONE ETHER GROUP | EMERY OLEOCHEMICALS GMBH (DE) | 2010-07-01 | — | — | US | disclosed |
| EP-2176205-A1 | METHOD FOR PRODUCING A COMPOUND WHICH HAS AT LEAST ONE ETHER GROUP | Emery Oleochemicals GmbH (DE) | 2010-04-21 | — | — | EP | disclosed |
| EP-2176204-A1 | METHOD FOR HYDROGENATING GLYCEROL | Emery Oleochemicals GmbH (DE) | 2010-04-21 | — | — | EP | disclosed |
| WO-2008151785-A1 | METHOD FOR PRODUCING A COMPOUND WHICH HAS AT LEAST ONE ETHER GROUP | COGNIS OLEOCHEMICALS GMBH (DE) | 2008-12-18 | — | — | WO | disclosed |
| WO-2008151784-A1 | METHOD FOR HYDROGENATING GLYCEROL | COGNIS OLEOCHEMICALS GMBH (DE) | 2008-12-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210251865-A1 | HYBRID QUATS IN, IN PARTICULAR, HAIR TREATMENT AGENTS | HHAT, DGAT2, QARS1 | FFAR1 1147/4885FFAR4 1114/4885FAAH 158/4885 |
| US-20240156704-A1 | FORMULATION COMPRISING ESTER QUATS BASED ON TRIALKANOLAMINES | SQLE, KHK, CUTA | FFAR1 418/4885FFAR4 584/4885FAAH 891/4885 |
| US-20140286889-A1 | FORMULATION COMPRISING ESTER QUATS BASED ON ISOPROPANOLAMINE | DLAT, HHAT, DGAT2 | FFAR1 972/4885FFAR4 1291/4885FAAH 292/4885 |
| US-11517515-B2 | Hybrid quats in, in particular, hair treatment agents | HHAT, DGAT2, QARS1 | FFAR1 1147/4885FFAR4 1114/4885FAAH 158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.